Three New Papers From Souweidane Team
Jan. 28, 2020 - Dr. Mark Souweidane and colleagues from the Weill Cornell Medicine Children’s Brain Tumor Project have published three new academic articles.
Gift From a Child Names CBTP a Center of Excellence
Jan. 15, 2020 - The Gift from a Child Initiative, primarily funded by family-founded nonprofit The Swifty Foundation, has designated the Children’s Brain Tumor Project at Weill Cornell Medicine to serve as its fifth named “Center of Excellence” in the US.
2019 Year in Review
Dec. 31, 2019 - The team at the Children's Brain Tumor Project is proud to share some of their key accomplishments from 2019.
No Laughing Matter 2019 Honoring Michael and Emmie Minter
October 18, 2019 - The second annual “No Laughing Matter” fundraiser honoring Mike and Emmie Minter raises almost $600,000.
Gliomatosis Cerebri Conference
Sept. 30, 2019 - The third Gliomatosis Cerebri (GC) Conference was held at the Abba Garden Hotel in Barcelona, Spain, on September 22–23, 2019, bringing together researchers, families, and nonprofits who share the same goal—to find a cure for this rare and deadly brain tumor.
International Gliomatosis Cerebri Conference 2019 in Barcelona
September 18 2020 - This year, the bi-annual gliomatosis cerebri conference was held in Barcelona, Spain. Stay tuned for more information about the 2021 conference.
Access to Experimental Drugs for Single-Patient Use Shows Promise in Pediatrics
June 28, 2019 - The Weill Cornell Medicine Children’s Brain Tumor Project is hopeful that single-patient use will work seamlessly in conjunction when designing patient-specific protocols based on genetic findings.
IronMatt Supports the CBTP
May 28, 2019 - The Children’s Brain Tumor Project is proud to announce another project funded by the Matthew Larson Foundation (aka IronMatt) beginning late 2019.
Do Something – Tara and Walker
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Prasent ac nibh vestibulum, laoreet ipsum.
Gliomatosis Cerebri – Letter from the Lab
December 1, 2018 - Read the latest "Letter from the Lab" highlighting some exciting discoveries pertaining to gliomatosis cerebri and potential new drug therapies.